Approval · Notice of Compliance 7863 · 2006
STREPTASE: Notice of Compliance 7863
Issued March 31, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7863
- Date
- March 31, 2006
- Company
- Zlb Behring GmbhKing Of Prussia, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Production process modifications
- Therapeutic class
- Fibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STREPTASE | Not yet assigned | — |
Medicinal ingredients
- STREPTOKINASE 250,000 UNIT per VIAL
- STREPTOKINASE 750,000 UNIT per VIAL
- STREPTOKINASE 1,500,000 UNIT per VIAL